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Abstract
Background: The Type I interferons (IFN) have major roles in the innate immune response to
viruses, a function that is believed to have led to expansion in the number and complexity of their
genes, although these genes have remained confined to single chromosomal region in all mammals
so far examined. IFNB and IFNE define the limits of the locus, with all other Type I IFN genes except
IFNK distributed between these boundaries, strongly suggesting that the locus has broadened as
IFN genes duplicated and then evolved into a series of distinct families.
Results: The Type I IFN locus in Bos taurus has undergone significant rearrangement and expansion
compared to mouse and human, however, with the constituent genes separated into two sub-loci
separated by >700 kb. The IFNW family is greatly expanded, comprising 24 potentially functional
genes and at least 8 pseudogenes. The IFNB (n = 6), represented in human and mouse by one copy,
are also present as multiple copies in Bos taurus. The IFNT, which encode a non-virally inducible,
ruminant-specific IFN secreted by the pre-implantation conceptus, are represented by three genes
and two pseudogenes. The latter have sequences intermediate between IFNT and IFNW. A new
Type I IFN family (IFNX) of four members, one of which is a pseudogene, appears to have diverged
from the IFNA lineage at least 83 million years ago, but is absent in all other sequenced genomes
with the possible exception of the horse, a non-ruminant herbivore.
Conclusion: In summary, we have provided the first comprehensive annotation of the Type I IFN
locus in Bos taurus, thereby providing an insight into the functional evolution of the Type I IFN in
ruminants. The diversity and global spread of the ruminant species may have required an expansion
of the Type I IFN locus and its constituent genes to provide broad anti-viral protection required
for foraging and foregut fermentation.
Background
Viruses are constantly evolving to find more effective
means to survive and multiply in their host species [1-3].
The immune defense system, in turn, exists in a perpetual
state of co-evolution with the pathogens to limit infec-
tious disease, a circumstance often likened to an "arms
race." The primary defense mechanism against viruses in
vertebrates is Type I IFN (interferon) of the innate
immune system [4]. It can reasonably be argued that com-
plex organisms like mammals can only survive as long as
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pathogens. Accordingly, a rapidly evolving, adaptable IFN
system is essential to mammals if they are to endure viral
infections. Type I IFN are also pleiotropic cytokines, with
significant roles in modulating adaptive immunity, cell
proliferation and cell death, and numerous other proc-
esses vital to mammalian health and survival [1]. Most
likely as a response to these challenges, Type I IFN dem-
onstrate a complex evolutionary history that has resulted
in the divergence of at least eight distinct subfamilies: IFN-
kappa (IFNK), IFN-beta (IFNB), IFN-epsilon (IFNE), IFN-
delta (IFND), IFN-zeta (IFNZ), IFN-alpha (IFNA), IFN-
omega (IFNW), and IFN-tau (IFNT) [5].
Mammalian Type I IFN probably emerged during tetra-
pod evolution from an older cytokine family, Type III IFN,
which provides the primary viral defense mechanism in
fish [6,7]. It is difficult to determine exactly when Type I
and Type III IFN diverged because no Type I IFN has been
identified in amphibians, but the split definitely occurred
prior to the divergence of birds and mammals approxi-
mately 310 million years ago (MYA) [5,8]. Type III IFN,
known more commonly in mammals as either IFN-
lambda (IFNL) or interleukin (IL)28 and IL29, is encoded
by a five exon gene, opposed to the single exon Type I IFN,
and acts through a different receptor complex than Type I
IFN [9,10]. Despite these differences, both Type I and
Type III IFN have similar mechanisms of induction, acti-
vate the same signaling pathways, and trigger the same
biological actions in the target cell [11]. Type III IFN has
been retained in some mammalian species including
humans and mice but has been lost in others [12]. Even
when present, it appears to have assumed a less dominant
role as an antiviral agent [11] and may have been sup-
planted as major player in antiviral defense with the emer-
gence of contemporary Type I IFN.
All Type I IFN elicit an antiviral response, but some may
play a more dominant role as first responders than others.
IFNA and IFNB were the first Type I IFN to be character-
ized in human and have been assumed to constitute and
the primary viral defense mechanism [13,14]. IFNA is
released by almost all cell types and a few of its family
members, specifically human IFNA2a and IFN2b, are cur-
rently approved for treatment of a range of viral diseases
including hepatitis B and C, condylomata acuminate
(genital warts), and AIDS-related Kaposi sarcoma [15].
IFNB is the main IFN secreted by fibroblasts in response
to a viral challenge, but is clearly produced by multiple
cell types [16]. It acts in the immediate antiviral response
and helps regulate the later expression of several IFNA
[17]. IFNW and IFNZ both appear to have developed spe-
cific niches in antiviral protection for certain species.
IFNW has been implicated in protection against specific
viruses, such as parvovirus, particularly in cats [18,19],
while murine IFNZ provides a unique combination of
high antiviral activity with relatively low lymphomyeolo-
suppresive activity [20], suggesting it may act to suppress
viruses targeting the bone marrow and spleen. IFNK is pre-
dominately expressed in keratinocytes where it is acts
through a unique cell-associated viral protection mecha-
nism [21,22]. IFNE is expressed in a variety of cell types,
but has been suggested on the basis of rather meager evi-
dence to serve a specific role in reproductive tissues either
in viral protection or early placental development [5,23].
IFND and IFNT, on the other hand, are not induced by
viruses but instead are released by the early pre-implanta-
tion embryos of swine and ruminant species, respectively,
where they appear to trigger responses in maternal uterine
endometrium that allow the pregnancy to become estab-
lished [24,25].
The arrangement of Type I IFN genes within the locus
likely reflects the origins and subsequent evolution of
individual family members. All Type I IFN in human and
mouse are clustered in an approximately 400 kb length of
DNA, located on the short arm of chromosome 9 (9p21)
in human and on the centromere-proximal region of
chromosome 4 (4C4) in mouse [26-28]. Two genes of
ancient origin, IFNB and IFNE, define the outer limits of
the locus. All the other Type I IFN genes, except IFNK, are
distributed between these two ancient genes, indicating
the locus has expanded internally as IFN genes duplicated
and then evolved into their respective families [27]. How-
ever, species-specific expansion and contraction of fami-
lies has occurred, with some IFN families only existing in
certain taxonomic groups. For example, IFND has only
been identified in the pig and is absent in the mouse and
human, while IFNZ is represented in the mouse, but only
remnants of the gene has been found in rats, while it is
completely absent in humans [20,25,29]. The IFNW,
which are considered to have arisen from the IFNA at least
129 MYA [16,30], constitute a particularly variable group-
ing. A single functional IFNW and at least two pseudo-
genes are present in humans, but only a single
pseudogene can be identified in mice [27]. Even more
bewildering, the family appears to have expanded in cats,
which, on the basis of cDNA evidence, possess at least 10
variants [31], but not even a relic of the open reading
frame can be found in the related carnivore, the dog [32].
Ruminant species, such as cattle, are known to possess
several, apparently functional, IFNW [33,34]. There is
also one example of a Type I family, the IFNT, that arose
relatively recently (36 MYA) in the lineage to the rumi-
nant artiodactyls. As a consequence, the IFNT are absent
from all species except those in the sub-order Ruminantia
[33,35]. Together, these data suggest that novel IFN genes
can be gained and existing genes discarded in response to
specific environmental challenges, which most likely
include threats from emerging new pathogens. In addi-Page 2 of 15
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unrelated to viral pathogenesis, as has occurred in the case
of the IFND [20,25,29].
Although it has been clear for some time that there are
similarities in the organization of the Type I IFN locus of
cattle and that of other species [36,37], it was equally evi-
dent that the bovine locus must have some unique fea-
tures, most notably because of the existence of the IFNT,
genes unique to ruminant species whose protein prod-
ucts, although active in antiviral assays, have a primary
role as hormones of pregnancy [38]. Cattle also have mul-
tiple IFNB while all non-ruminant species so far examined
possess only a single copy IFNB [5]. Together these find-
ings suggest either a decreased restriction on duplication
of Type I IFN genes in cattle or evolutionary pressure to
acquire additional genes. The recent sequencing of the
bovine genome has provided the first opportunity for a
detailed study of the Type I IFN locus in a ruminant spe-
cies. Here we provide a detailed description and full anno-
tation of the bovine locus and some inferences about its
evolutionary history.
Methods
Annotation
Most of the IFN gene candidates were identified through
the National Center for Biotechnology and Information
(NCBI)'s bovine genome resource by using the basic local
alignment search tools (BLAST)
http:www.ncbi.nlm.nih.gov/genome/seq/BlastGen/Blast
Gen.cgi?taxid=9913[39]. Additional searches were per-
formed through NCBI by using the appropriate genome
resource http://www.ncbi.nlm.nih.gov/mapview/[40] for
other species, which are discussed later in this section, and
by using the basic nucleotide BLAST suite http://
www.ncbi.nlm.nih.gov/blast/
Blast.cgi?CMD=Web&PAGE_TYPE=BlastHome[41,42].
Several combinations of BLAST algorithms and databases
within NCBI were utilized for this work and are described
below [43].
BLAST algorithms
1. MegaBLAST was designed to compare highly related
nucleotide sequences and works best when the target
sequence has a 95% identity or higher to the query
sequence.
2. Cross-species megaBLAST, also referred to as discontig-
uous BLAST, is a derivative of megBLAST that ignores cer-
tain bases, thereby allowing mismatches. It was designed
to compare nucleotide sequences from one species to
nucleotide sequences in another species.
3. BLASTN also compares nucleotide query sequences to a
nucleotide database. This algorithm is slower than megaB-
LAST, but it can identify shorter sequence matches than
megaBLAST. It was not specifically designed for cross-spe-
cies comparisons.
4. TBLASTN was designed to compare a protein sequence
with a nucleotide database dynamically translated in all
reading frames.
NCBI databases
1. The "genome (reference)" database represents the most
current publicly available assembly of a genome. The
most current assembly of the bovine genome at the time
this work was completed was assembly 3.1. The most cur-
rent assembly for other species examined in this work are
placed in parenthesis here – human (36.2), mouse (37.1),
horse (1.1), and dog (2.1).
2. The "WGS contigs" database contains the contigs, or
overlapping unassembled sequences, that forms the basis
for the assembled genome. Both pig and cat do not have
an assembled genome available at this time and only the
"WGS contigs" database could be searched for genomic
information for these species.
3. The "traces-WGS" database contains the trace data for
whole genome shotgun sequence (WGS) bacterial artifi-
cial chromosome (BAC) end sequencing. This database
contains single pass sequencing reads that are not
trimmed based on quality or vector contamination.
4. The "nucleotide collection (nr/nt)" database contains
all Genbank, RefSeq, EMBL (Europe's primary nucleotide
database), DNA Database of Japan (DDJB), and many
Protein Databank (PDB) sequences. The "nucleotide (nr/
nt)" database is subdivided into "human nucleotide (nr/
nt)," "mouse nucleotide (nr/nt)," and "others nucleotide
(nr/nt)" databases. The "others nucleotide (nr/nt)" data-
base does not contain any mouse or human sequences.
Bovine IFNB, IFNA, IFNW, and IFNT cDNA sequences
(Table 1) from GenBank were used to perform a megaB-
LAST search in the bovine "genome (resource)" database.
Human IFNE, murine IFNZ, porcine IFND, human IFNK,
and human IFNL/IL28-29 sequences (Table 1) were que-
ried with cross-species megaBLAST in the bovine "genome
(reference)" database because no bovine homologues for
the latter group of genes have been reported. The trans-
lated sequence for each of the non-bovine IFN cDNA were
also queried with TBLASTN in the bovine "genome (refer-
ence)" database because the TBLASTN algorithm can
often identify homologues that are not detected through
other searches. IFNL/IL28-29 nucleotide and amino acid
sequence were also queried in the bovine "WGS contig"
database by using a cross-species megaBLAST and
TBLASTN search, respectively, to verify no sequence withPage 3 of 15
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missed. Specific genes were analyzed in the bovine
"traces-WGS" database to verify frameshift mutations or
nucleotide variations from the query sequences.
The Bovine Genome Sequencing and Annotation Consor-
tium created a consensus predicted gene set through an
algorithm, termed GLEAN, developed during the annota-
tion of the honey bee that used latent class analysis to
automatically combine disparate gene prediction evi-
dence [44]. Since the majority of positive megaBLAST,
cross-species megaBLAST, and TBLASTN matches were
clustered on two scaffolds, Chr8.25 [Genbank:
NW_001495421] and Chr8.34 [Gen-
bank:NW_001495430], all GLEAN models on those two
scaffolds were also annotated through Apollo http://
apollo.berkeleybop.org/current/index.html[45,46]. In
brief, Apollo is a genome annotation viewer and editor
that was originally designed for the annotation of the Dro-
sophila melanogaster genome. The Bovine Genome
Sequencing and Annotation Consortium created input
files for Apollo containing EST matches, cDNA matches,
translated protein matches, and gene model data includ-
ing all GLEAN models for the bovine genome assembly
3.1. GLEAN models present on scaffolds Chr8.25 and
Chr8.34 that had not been identified in the aforemen-
tioned searches were queried through BLASTN and dis-
contiguous megaBLAST in the "others nucleotide
collection (nr/nt)" and "human nucleotide collection (nr/
nt)" databases to verify their status as IFN genes or
another gene family. Discontiguous megaBLAST and
TBLASTN searches in human, mouse, equine, porcine,
feline, and canine "genomic (reference)" and "WGS con-
tigs" databases were performed for the unique IFN family
discovered during the annotation of Chr8.34.
The 64 identified IFN genes and pseudogenes and the
original query cDNA from Genbank (Table 1) were
aligned through CLUSTALW in BioEdit version 7.09 http:/
/www.mbio.ncsu.edu/BioEdit/BioEdit.html[47,48]. A
pairwise comparison to known IFN nucleotide sequences
was performed through the Maximum Composite Likeli-
hood method in MEGA version 4 (MEGA4) http://
www.megasoftware.net/[49] to determine the IFN family
for each gene [50,51].
IFNT was queried with megaBLAST in the bovine "traces-
WGS" database to validate the number of IFN genes
present in the genome. Bovine sequence matches that had
greater than 94% sequence identities to the query IFNT for
more than 400 basepairs (bp) were visually inspected. An
IFNT match was counted as a positive if the sequence had
greater than 98% identity to an IFNT cDNA in the portion
of the trace with a quality score, available through NCBI,
higher than 40 on a scale between 0 and 100. The total
number of IFNT matches in the WGS contig database was
divided by the bovine genome coverage to approximate
the total IFNT gene number.
Phylogenetic Reconstruction
Alignments for the genomic IFN ORFs were created
through ClustalW in BioEdit version 7.09, with individual
genes denoted by their GLEAN numbers. Phylogenetic
trees were constructed in MEGA4 through the Neighbor-
joining (NJ) method with bootstrapping test (1000 repli-
cates). The tree was rooted to IFNK [5] and a second tree
was created with the assumption of a non-uniform rate of
change between sites (gamma = 1).
Identification of repetitive elements
The localization and identity of all repetitive elements
were determined by using the RepeatMasker program
http://www.repeatmasker.org/[52], which uses the Rep-
Base library of repeat elements [53]. Sub-locus 1, corre-
sponding to 20000–711500 bp in scaffold Chr8.25, and
sub-locus 2, corresponding to 2000–446000 bp in scaf-
fold Chr8.34, sequences were first selected through
Apollo and imported into a word processing program,
Microsoft Word. All gaps within the scaffolds, which are
represented by an "N" in the bovine assembly, were
removed manually. IFN sub-loci sequences were then ana-
lyzed in RepeatMasker version 3.1.9 run in default mode
Table 1: Query sequences used for the genomic searches.
Species Gene Accession No. Species Gene Accession No.
Bovine IFNA AY325272 Bovine IFNT AF196324
Bovine IFNA M10954 Porcine IFND Z22707
Bovine IFNA AY523531 Porcine IFND Z22706
Bovine IFNA DQ396807 Human IFNK NM_020124
Bovine IFNA Z46508 Human IFNE NM_176891
Bovine IFNB M15478 Human IFNL AY184374
Bovine IFNW M11002 Human IFNL AY184373
Bovine IFNT M31557 Human IFNL AY184372
Bovine IFNT AF196320 Murine IFNZ NM_197889
Bovine IFNT AF196322Page 4 of 15
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[54] to determine the percentage of repetitive elements.
Bos taurus was set as the assumed species within the pro-
gram parameters. Simple repeats and low complexity
regions were not masked, which means they were not
excluded as start sites for a BLAST match, and the matrix
was optimized for 42% GC content based on sub-loci
optimization pre-runs.
Results and discussion
IFN Gene Families in Bos taurus
Evidence for the presence of all previously known Type I
IFN subfamilies except IFNZ was found on chromosome
8 of the bovine genome assembly 3.1 (Table 2). IFNZ has
only been reported in mouse [27,55], and so its absence
in Bos taurus was anticipated. Both IFNK and IFNE are
present as single genes with intact ORF and are assumed
to be functional, providing the first evidence that either of
these subfamilies is present in ruminants. Bovine IFNK
and IFNE have 81.2% and 84.7% nucleotide identity
respectively when compared to their human orthologues,
values that are similar to their degree of conservation
between human, cat, dog, and pig (A. Walker, unpub-
lished data). The IFNW family is greatly expanded com-
pared to other species that have so far been examined.
There are 24 potential IFNW and at least 8 pseudogenes.
The query IFNW [Genbank:M11002] [34] exactly matches
two IFNW annotated from the genome database (GLEAN
09983 [Bovine Genome Database temporary ID:2733]
and GLEAN 10004 [Bovine Genome Database temporary
ID: 2525]). The remaining IFNW range in sequence iden-
tity from 86% to 96% relative to the query sequence.
The IFNA and IFNB are also present in multiple copies,
with 13 and 6 genes, respectively, although neither family
is as large as the IFNW. An apparent IFNB pseudogene,
deemed nonfunctional due to a frameshift deletion, also
exists.
IFND are only represented as three pseudogenes, a not
unexpected finding, as a functional gene has only been
reported previously for the pig [56].
Three apparently functional IFNT are found within the
locus. Surprisingly none of these provide an exact match
for any of the many cDNA and gene sequences that have
previously been reported. Previous mRNA sequencing of
the IFNT family had indicated that at least 18 bovine IFNT
might exist [57]. Only three IFNT are present in the
bovine genome assembly 3.1, however. One particular,
well established sub-family, the IFNT2 grouping [57], is
not represented at all in the assembly. Additional analysis
revealed 45 acceptable matches to IFNT in the WGS contig
database. Since the bovine genome at this time has 7.1 X
coverage, the number of IFNT matches divided by this
coverage value suggests the possibility of around six IFNT.
One explanation is that these "extra" genes have been lost
in the assembly process, but even this higher value is still
significantly lower than the 10 to 18 IFNT previously
believed to exist. Some of the latter are most likely alleles.
Most interestingly, we detected a novel Type I IFN, which,
as we shall discuss later, consists of three potentially func-
tional genes and one pseudogene, none of which provides
a close sequence match with any previously described
Type I IFN. For convenience, and until an appropriate
nomenclature is approved, this new family will be termed
IFNX.
A weak sequence identity to IFNL was found on chromo-
some 13, specifically located on scaffold Chr13.80 [Gen-
bank:NW_001493172] from 635,850 to 636,120 bp. This
sequence appears not to encode a functional gene in
either the 3.1 assembly or the WGS contig database. These
data suggest that the Type III IFN family exists only as a
relic and is no longer a functional component in bovine
pathogen defenses.
Locus Map
The Type I IFN locus is organized similarly in mouse and
human, and possibly also in pig, i.e. there is relatively
conserved synteny across rodents, primates, and swine.
Two mammalian IFN genes of ancient origin, IFNB and
IFNE, define the outer limits of the locus, with all the
other genes, except IFNK, distributed between these two
markers. The genes are predominantly (but not exclu-
sively) localized on one strand and transcribed in the
same direction as the IFNB and IFNE [27]. The relative
Table 2: Cross-species comparison of IFN subfamilies.
Gene Number
Subfamily Human Mouse Cow
IFNK 1 1 1
IFNE 1 1 1
IFNB 1 1 6
IFND 0 0 0
IFNZ 0 2 0
IFNA 13 14 13
IFNW 1 0 24
IFNT 0 0 3
IFNX 0 0 3
IFNL 3 3 0
The number of predicted IFN genes in each subfamily based on 
genomic analysis of the mouse, human, and bovine are shown. 
Predicted pseudogenes based on frameshift mutations or stop codons 
within the first 100 aa of the coding sequence have been excluded 
from the table. The bovine Type I IFN locus has an expansion of both 
the IFNB and IFNW subfamilies. Cattle have also acquired two novel 
IFN subfamilies, IFNT and a previously unidentified IFN family, termed 
IFNX, discovered during this analysis.Page 5 of 15
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IFN locus are illustrated in Fig. 1. The bovine Type I IFN
locus is clearly organized differently than that of the other
two species. Instead of a single stretch of DNA defining
the locus, cattle have two sub-loci (1 & 2) encompassing
701 kb and 441 kb, respectively, separated by a gap esti-
mated to be approximately 11 megabases (Mb) in assem-
bly 3.1 (but ~750 kb in assembly 4.0). The gene density
based on the both predicted open reading frames (Gene
Sequence map) and bovine EST and mRNA alignments
with the assembled sequence (BT UniG map) is lower in
the region between the two IFN sub-loci than much of the
rest of chromosome 8, but many genes are present and
actively transcribed.
The following explanation of the locus organization has
been based on the chromosome map assigned during the
assembly process and reported by NCBI (Fig. 2). An IFNB
defines the distal end (relative to the start of the chromo-
some map) of sub-locus 2 (Fig. 1 &2). IFNE, while present
in the bovine, is located towards the distal end of sub-
locus 1. The majority of the genes in both sub-loci are
transcribed in the same direction as the distally placed
IFNB, except one cluster of IFNW and IFNA and the soli-
tary IFNE, which are transcribed in the opposite direction.
IFNK is present in a single "copy" nearer to the start of the
chromosome map and well separated (6.044 Mb) from
the closest sub-locus (sub-locus 1) (Fig. 1). The bovine
IFNK location is very similar to that in the human where
a single IFNK is located 6.5 Mb from the Type I IFN locus
[22] (Fig. 1).
There are three clusters of IFNA/IFNW. Two of them are
on sub-locus 1, one at the proximal end, the second
placed about half way along (Fig. 2). A gene set in the first
IFNA/IFNW cluster 1 is a palindrome to one in the second
cluster. The corresponding gene pairs have complete
nucleotide identity within their coding regions, suggesting
that the duplication or gene conversion event that led to
their formation occurred quite recently. The third cluster
of IFNA/IFNW is at the distal end of sub-locus 2, but lacks
the duplicated group of four genes in IFNA/IFNW clusters
1 and 2.
Only one non-IFN gene is detectable within sub-loci 1
and 2, an intronless kelch-like 9 (KLHL9) located 33.5 kb
proximal to IFNA/IFNW cluster 2 in sub-locus 1 (Fig. 2).
The orthologous KLHL9 gene can be found in the Type I
IFN locus of the mouse approximately 25 kb from the
nearest functional IFN (IFNA8) [27] and 29 kb from the
nearest IFN (IFNA6) in human. The fact KLHL9 has
resisted duplication despite residing close to genes under-
going multiple duplications is noteworthy and possibly
indicates that multiple copies of this gene are not well tol-
erated.
The presence of KLHL9, which appears to be under differ-
ent evolutionary constraints than IFNW and IFNA, close
to IFNA/IFNW cluster 2 suggested the cluster as whole
might be under different evolutionary control than cluster
1 or 3. Evolutionary divergence rates do not indicate that
this is the case, however (Table 3). While cluster 1 does
have a slightly higher divergence rate than cluster 2, all
Type I IFN locus schematicsFigure 1
Type I IFN locus schematics. These schematics, while not drawn to scale, illustrate the basic characteristics of the locus in 
mouse and human, the Conserved Locus Schematic, and the bovine locus. Each IFN gene is represented by its abbreviated 
name and its position above and below the schematic line represents the direction of its transcription.Page 6 of 15
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Inter-cluster divergence is actually very low in all three of
the IFNA/IFNW clusters.
The IFNT and two IFNW pseudogenes are neighbors at the
distal end of sub-locus 1, suggesting that this cluster of
genes originated from an IFNW that had become isolated
from other IFNW before the divergence of the IFNT. Its
unique position outside the IFNA/IFNW clusters and
close to the edge of the sub-locus may have permitted the
rapid expansion and evolution of the IFNT family without
the restraints placed on the clustered IFNW.
All non-ruminant species examined to date, including
mouse, human, cats, dogs, rabbits, and pigs, contain only
one IFNB [16]. In cattle, this family has clearly expanded
and extends from the distal end of IFNA/IFNW cluster 3 to
the end of sub-locus 2. Interspersed within these multiple
IFNB are members of the previously unidentified IFN
family, IFNX. Again, it is tempting to hypothesize that the
IFNX and expanded IFNB family were able to emerge due
to their location on the edge of the sub-locus 2, as sug-
gested for the IFNT in sub-locus 1.
Repetitive Elements within Sub-loci
Repetitive elements have been implicated in gene duplica-
tion by creating regions predisposed to homologous
recombination [58,59] and also in organizing the assem-
bly of enhanceasomes, as recently described for transcrip-
tion of IFNB [60]. Over one third of the bovine Type I IFN
locus consists of interspersed repeats, rather less than the
43% assessed for the murine Type I IFN locus [27].
Repeats are more enriched in sub-locus 1 largely because
of the presence of a greater number of long interspersed
nucleotide elements (LINE) and long terminal repeats
(LTR) (Table 4). LINE2 elements are absent in both sub-
loci. Short interspersed nucleotide elements (SINE)s are
present in similar proportions, approximately 15%, for
both sub-loci. The arrangement of these elements pro-
vides no obvious insight into whether the sequences are
involved in gene duplication or in controlling transcrip-
tion.
Genomic map of the bovine Type I IFN locusFigure 2
Genomic map of the bovine Type I IFN locus. Blast searches of the bovine genome database revealed that all matches to 
known IFN genes, except IFNK, reside within two sub-loci, illustrated in the gene map shown in Fig. 2. Both the position of each 
gene relative to the line and the direction of the arrow on the map denote the direction of transcription. The subfamily for 
each gene is designated by the final letter of the abbreviated name. Pseudogenes are indicated by a box instead of an arrow and 
the letter "p" after the subfamily designation. Specific gene clusters have been labeled according to the subfamily or subfamilies 
they contain. A recent example of gene duplication is illustrated in the IFNW/IFNA cluster 1 and 2. The bracketed gene set in 
IFNA/IFNW cluster 1 is a palindrome to the bracketed gene set in the IFNA/IFNW cluster 2 with identical coding sequences for 
genes specified by correspondingly colored boxes.
Table 3: Divergence within IFNA/IFNW clusters.
IFNA/IFNW Clusters
Subfamily 1 2 3
IFNW 0.086 ± 0.007 0.071 ± 0.007 0.063 ± 0.006
IFNA 0.053 ± 0.006 0.04 ± 0.006 0.045 ± 0.006
Divergence rate ± standard error for IFNA and IFNW within clusters 
was calculated by using the Maximum Composite Likelihood method. 
The number of base substitutions per site from averaging over all 
sequence pairs within each cluster is shown. Cluster 1 genes have a 
slightly higher divergence rate than cluster 1 and 2, but genes within 
all three clusters are relatively equal in their rate of change.Page 7 of 15
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BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187Palindromic IFN within IFNA/IFNW clusters 1 and 2
As mentioned previously, a gene set located on the distal
end of IFNA/IFNW cluster 1 is a palindrome to a gene set
on the distal end of cluster 2 (Fig. 3A). Two IFNA and two
IFNW are present in each gene set and these are desig-
nated as A(1) and A(2) for the two IFNA and W(1) and
W(2) for the two IFNW in cluster 1. A(1) and A(2) are
located at the proximal and distal ends of the gene set in
cluster 1, respectively. W(1) and W(2) are located from
proximal to distal between A(1) and A(2). The genes with
identical ORFs in cluster 2 are designated as A(1)/, A(2)/,
W(1)/, and W(2)/ (Fig. 3B). The ORF and the first 350 bp
of the 3/ UTR for the two IFNA and IFNW gene pairs are
identical, and an approximately 550 bp promoter for both
IFNA gene pairs and the W(2)/W(2)/ pair are also identi-
cal. The promoters of the W(1)/W(1)/pair, while closely
similar (99%), are not identical, however. All nucleotide
differences between the W(1)/W(1)/ gene pair are within
a region between 300 bp and 400 bp upstream of the tran-
scriptional start site.
Two different evolutionary processes, either gene duplica-
tion or gene conversion, could possibly explain the exist-
ence of the IFNA/IFNW palindromic gene sets. Gene
duplication involves the formation of a new gene copy.
Gene conversion, on the other hand, does not generate
new gene copies, but instead homogenizes existing genes.
Both gene duplication and gene conversion have been
specifically implicated in the evolution of the IFNA in
human, chimpanzee, dog, rhesus monkey, rat, and mouse
[30,61,62]. Gene conversion, specifically, was predicted
by two different statistical programs, GARD and GENE-
CONV, in humans, chimpanzee, rhesus monkey, and
mice. Furthermore, despite IFNA genes aligning in con-
served positions on a locus map for chimpanzees and
humans, the subfamily separated into species-specific
clades on phylogenetic analysis [61], strongly indicating
gene conversion has occurred in the IFNA subfamily in
these two species. Although gene duplications cannot be
unambiguously distinguished from gene conversions
[63], the latter seldom involve sequence longer than 1 kb
in mammals, with 3 kb considered the maximum length
[63]. Therefore, when the sequence tract involved is "too
large" for gene conversion, gene duplication is usually
implicated [64]. The palindomic gene set involves at least
a 27 kb tract, far exceeding this size limit and reducing the
likelihood of a conversion event. Therefore, a segmental
duplication event, which is a specific type of gene duplica-
tion that involves a large segment of a locus, combined
with an inversion is the best explanation for the palin-
drome [65].
Selective Pressure on the ORF of Type I IFN Subfamilies
Comparison of the rate of non-synonymous nucleotide
change relative to the rate of synonymous change can pro-
vide information about the type of selection operating on
the members of a multigene families [66]. If neutral selec-
tion is occurring, then all nucleotides in a sequence are
equally likely to change. Consequently the rate of synon-
ymous nucleotide changes (dS) will be equal to the rate of
non-synonymous changes (dN) and dS:dN will equal 1.
Rapid change in the amino acid sequence is the desired
endpoint for positive selective pressure. Hence, in this sce-
nario, dN will exceed dS, and dN:dS will be greater than 1.
Conversely, if strong selection against amino acid change
is present (purifying selection), dN will be less than dS
and dN:dS will be less than 1. Virtually all pairwise com-
parisons within IFNA, whatever the species [61,67], and
IFNT [57] have shown the overall value for dN not to be
significantly higher than dS. Indeed, dN values have been
generally calculated to be lower than dS, consistent with
the conclusion that there has not been strong positive
selection for amino acid change within the coding regions
of these subfamilies of IFN.
Table 4: Repetitive elements within the bovine Type I IFN sub-
loci.
Sub-locus 1 Sub-locus 2
SINEs: 15.29% 15.68%
Alu/B1 0.00% 0.00%
MIRs 0.51% 0.81%
LINEs: 17.74% 11.23%
LINE1 10.33% 2.20%
LINE2 0.44% 0.29%
L3/CR1 0.04% 0.00%
RTE 6.93% 8.73%
LTR elements: 4.01% 2.75%
MaLRs 0.89% 0.98%
ERVL 0.12% 0.03%
ERV classI 0.79% 0.22%
ERV classII 0.00% 0.00%
DNA elements: 2.36% 2.68%
MER1_type 1.72% 2.45%
MER2_type 0.45% 0.00%
Unclassified: 0.00% 0.00%
Total interspersed repeats: 39.40% 32.35%
Small RNA: 0.24% 0.40%
The percentage of repetitive elements for the Type I IFN sub-loci was 
calculated in RepeatMasker 3.1.9. The length of nucleotide sequence 
encompassing the repetitive element divided by the length of the total 
nucleotide sequence for either sub-locus 1 or sub-locus 2 was used to 
calculate the percentage shown in each column. Sub-locus 1 has a 
higher proportion of LINE1 and LTR elements than sub-locus 2 
resulting in a higher total number of interspersed repeats within sub-
locus.Page 8 of 15
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BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187The dN:dS for all multigene bovine IFN subfamilies,
including only IFN annotated during this work, is illus-
trated in Fig. 4. The dN and dS values for every gene pair
in a Type I IFN subfamily were calculated and plotted
against each other. No multigene IFN subfamily (IFNA,
IFNB, IFNW, or IFNT) in bovine has a dN significantly
exceeding dS. In fact, bovine IFNA and IFNW provide
strong evidence for purifying selection. The significance of
purifying selection within IFNW and IFNA subfamilies
was also verified through a codon based Z-test (p <
0.001), which determines selective pressure for a gene pair
or group of genes based on the difference between dN and
dS through a one-tailed t-test (Table 5). Four IFNB pairs
out of 15 pairwise comparisons examined provide some
Palindromic gene sets within IFNA/IFNW clusters 1 and 2Figure 3
Palindromic gene sets within IFNA/IFNW clusters 1 and 2. (A) An enlarged image of IFNA/IFNW clusters 1 and 2 from 
Fig. 2 is shown. (B) The promoter (Pr), ORF, and 3/ UTR for each gene have been depicted in a schematic of both gene sets 
(not drawn to scale). The direction of gene transcription is indicated by an arrow above each gene and the GLEAN number is 
written below each gene (GLEAN 09981 [Bovine Genome Database temporary ID:2371], GLEAN 09982 [Bovine Genome 
Database temporary ID:2258], GLEAN 09983 [Bovine Genome Database temporary ID:2733], GLEAN 09984 [Bovine 
Genome Database temporary ID:1340], GLEAN 10002 [Bovine Genome Database temporary ID:1155], GLEAN 10003 
[Bovine Genome Database temporary ID:2217], GLEAN 10004 [Bovine Genome Database temporary ID:2525], GLEAN 
10005 [Bovine Genome Database temporary ID:74]. Genes with 100% nucleotide identity within their promoters, ORFs, and 
3/ UTRs are shown in matching solid colors. The only gene pair that does not have 100% nucleotide identity in the promoter, 
W(1)/W(1)/, is indicated by diagonal stripes through the promoter box.Page 9 of 15
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BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187evidence for purifying selection on the basis of the pair-
wise codon based Z-test (Table 6), but such selective pres-
sures are not evident for the family as a whole (p = 0.171).
On the other hand, the same test employed for neutral
selection provided no evidence for a lack of selective pres-
sure operating on any members of the IFNB subfamily (p
= 0.343), indicating the six genes comprising the bovine
IFNB subfamily may be too few for a meaningful analysis.
Since only three IFNT were identified, statistical analysis
of this subfamily from the genomic data was not possible.
The classic model of gene duplication states that after a
duplication event one gene continues to perform the
ancestral function while the second either rapidly evolves
to fill a new niche or becomes inactive [65,68,69]. As a
consequence gene duplication is usually followed by a
period in which there is an acquisition of non-synony-
mous nucleotide changes in one of the two genes, leading
to a divergence in amino acid sequence. This temporary
relaxation of purifying selection, in which dN:dS
approaches 1, permits the gene to become fine-tuned to
its new role or, more commonly, results in pseudogeniza-
tion. Such a sequence of events does not appear to have
occurred during the large scale expansion of the IFNW
family where there is strong evidence for purifying selec-
tion operating on the coding regions of the genes (Fig. 4
& Table 5). One potential explanation is that sub-func-
tionalization is occurring through alterations in the man-
ner in which these genes are subjected to transcriptional
control rather than in the structure of the proteins them-
selves. Evidence for positive selective pressure in the regu-
latory regions of IFNW would strongly support this
hypothesis, but a detailed promoter analysis is beyond the
scope of this work.
IFNX: Evidence for a novel subfamily
Based on the current assembly, the IFNX subfamily con-
sists of three potential genes and one probable pseudog-
ene. The origin of these genes is currently unclear, but they
appear to constitute a unique IFN subfamily, whose clos-
est relatives are the IFNA based on a Maximum Compos-
ite Likelihood divergence analysis, with IFNX sharing over
65% nucleotide identity to IFNA and only about 45%
nucleotide identity to IFNB. They are clearly defined on
phylogenetic trees based on their ORF as a distinct clade
that is most closely related to IFNA; however, phyloge-
netic analyses are conflicting with regard to when IFNX
first appeared. Phylogenetic trees calculated on the
assumption that all nucleotide sites within the coding
sequence change at the same rate indicate IFNA separated
from IFNX prior to or corresponding with the radiation of
eutherian mammals, i.e. more than 150 MYA [35] (Fig.
5A). Conversely, phylogenetic trees that take into account
substitution rate variation from site to site indicate that
bovine IFNX and bovine IFNA emerged from a common
ancestor after the radiation of the major mammalian
orders (Fig. 5B). In other words, this model recognizes
that certain amino acids and, by corollary certain nucle-
otides, are more highly conserved than others across sub-
families. This second model most closely matches the
amino acid differences among IFN subfamilies, since
amino acids critical to preserving the tertiary structures of
IFNB, IFNA, IFNT, and IFNL are much more highly con-
served than ones in less critical regions of the proteins
[55,70]. Preliminary examination of IFNX indicate some
of the more highly conserved amino acids for other Type
I IFN, such as cysteine residues 1 and 99 (discussed
below), are also conserved in IFNX. In addition IFNX and
the IFNX pseudogene are absent in human, mouse, por-
cine, feline, and canine genomic databases, yet some rem-
nants of their presence might be expected if this family
emerged early in the evolution of mammals and prior to
the main radiation events.
Two of the three potential IFNX genes contain the four
conserved cysteine residues required for the disulfide
bonds (1–99; 29–139) encountered in IFNA and those
Type I subfamilies that emerged from IFNA, namely
IFNW, IFND, and IFNT. The third potential gene, GLEAN
24316 [Bovine Genome Database temporary ID:2755],
contains an early termination codon at codon 125, which
eliminates the second disulfide bond (29–139) (Fig. 6),
raising the possibility that it is a second pseudogene. The
"trace-WGS" database was visually examined to verify the
presence of this early stop codon. Five BACs, all of which
were in the minus orientation, contained sequences that
exactly matched the complementary sequence to Glean
24316, i.e. all contained the early termination codon.
Previous studies of IFNA have identified three regions that
are strongly associated with IFN-receptor interaction and
are termed interferon receptor recognition peptides
(IRRP)1–3 [70-72]. IRRP1 (27–35) and IRRP2 (78–105)
control the initial binding of IFN to the Type I receptor
and are highly conserved among IFNA. IRRP3 (123–140)
modulates the downstream signaling pathways, so that
amino acid changes in this region can explain some differ-
Table 5: Purifying selection within IFNW and IFNA coding 
regions.
Family p-Value dS-dN
IFNA 0.0 3.824
IFNW 0.0 4.013
The significance of purifying selection in the coding regions of IFNW 
and IFNA subfamilies was verified through a codon based Z-test 
analyzing the overall average for the subfamilies. The p-value is shown 
in the second column with p-values less than 0.05 considered 
significant. The test statistic, the difference between dN and dS, is 
shown in the third column. The variance of the difference was 
computed by using the bootstrap method (1000 replicates).Page 10 of 15
(page number not for citation purposes)
BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187
Page 11 of 15
(page number not for citation purposes)
Table 6: Selection in IFNB.
24309 24311 24313 24315 24317 24318
IFNB (24309)
IFNB (24311) 0.486
IFNB (24313) 1.000 1.000
IFNB (24315) 0.032 0.339 0.342
IFNB (24317) 0.303 1.000 1.000 0.036
IFNB (24318) 0.150 1.000 1.000 0.008 0.050
Pairwise comparisons between IFNB through the codon based Z-test are shown in the above table with the statistically significant comparisons 
underlined.
Selective Pressure on the coding regions of bovine Type I IFNFigure 4
Selective Pressure on the coding regions of bovine Type I IFN. Pairwise analysis of the coding region between every 
gene pair in a Type I IFN subfamily was used to calculate dS and dN, and the two values were plotted against one another. No 
comparisons were made between genes belonging to different subfamilies, i.e. an IFNB gene and an IFNA gene. In addition, all 
probable pseudogenes, which contained early stop codons or frameshift mutations, were not included in the analysis. The grey 
diagonal line in the graph represent neutral selection rate where dS = dN. Gene pairs undergoing positive selection would 
appear above the diagonal and gene pairs undergoing purifying selection would appear below the diagonal. The graph clearly 
shows that no positive selection is occurring within the coding regions of any Type I IFN family. Furthermore, IFNW and IFNA 
subfamilies appear to be undergoing purifying selection.
BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187ences in biological activity among different IFNA. The
protein products of the three IFNX do not possess identi-
cal IRRP1 and IRRP2 motifs as IFNA, but these two
regions are highly conserved within the subfamily,
emphasizing, first, the possible importance of this motif
and second that the IFNX family is unique and distinct
from IFNA. IRRP3 was absent in GLEAN 24316 again sug-
gesting that it may be a pseudogene. The two remaining
IFNX members differed in their IRRP3 sequences, a not
unexpected finding as changes in this region may provide
subtle differences in biologic activity between the two
family members. None of the IFNX genes contain the N-
glycosylation sequence (N-X-S/T) common in other Type
I IFNs that could alter IFN-receptor interaction.
No evidence for IFNX expression could be found in any
EST databases, although, genes with high identity to IFNX
exist in the equine genomic database. The conservation of
The Bovine Type I IFN Phylogenetic TreeFigure 5
The Bovine Type I IFN Phylogenetic Tree. (A) The evolutionary history of bovine Type I IFN was inferred by using the 
Neighbor-Joining (NJ) method with bootstrap test (1000 replicates). The tree was rooted to IFNK and calculations were based 
on uniform rates of change for all sites. IFNX emerged prior to IFNA in this analysis. (B) The tree illustrates the evolutionary 
history of bovine IFN based on different rates of change between sites (gamma = 1). The tree was again based on the NJ 
method with bootstrap test (1000 replicates) and rooted to IFNK. IFNX and IFNA branched from a common ancestor in this 
analysis.Page 12 of 15
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BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187this gene family in species that diverged at least 80 million
years ago suggests that the family may have an important
function in ungulates. However, the apparent absence of
IFNX genes in pigs, also an ungulate, is puzzling. Possibly,
IFNX has a specific function in herbivores that is not
required in omnivores, most likely in immune defense
against particular viruses or other pathogenic organisms
affecting such species.
The identification of a novel Type I IFN gene, the IFNX, is
an unexpected and possibly important finding. The pro-
teins encoded by this family of genes differ sufficiently in
primary sequence from related Type I IFN to justify a sep-
arate designation from the related IFNA and IFNB. The
presence of a distinct cluster of IFNX within the Type I IFN
locus, the phylogenetic position of IFNX as a separate
clade within the IFN tree, and the conservation of critical
amino acid residues, are totally consistent with classifying
the IFNX as a distinct Type I IFN subfamily. Whether IFNX
are responsive to a viral challenge and able to interact with
the Type I IFN receptor and elicit a typical Type I response
in their target cells has yet to be verified. Substantial work
will be necessary to characterize this subfamily fully, but
its place as a separate clade within the Type I IFN would
appear to be assured.
Conclusion
The Type I IFN locus has undergone substantial transfor-
mation in ruminants compared to humans and mice. The
conserved locus structure has been transformed, sub-
families have expanded, and two subfamilies not present
in either humans or mice exist. The division of the locus
into two sub-loci may have provided an opportunity for
genes to duplicate and contribute to an expanded func-
tion of the Type I IFN. The divergence of the successful
pecoran ruminant sub-order and its geographic spread
might have required improved protection against unique
ruminant pathogens. The IFNX sub-family and the greatly
expanded ruminant specific IFNW are likely candidates
for providing such protection. Radically new functions for
IFNX alignmentFigure 6
IFNX alignment. The coding region, minus the predicted signal peptide, for the three predicted IFNX genes are denoted by 
their GLEAN numbers (24314 [Bovine Genome Database temporary ID:2633], 24310 [Bovine Genome Database temporary 
ID:2546], and 24316 [Bovine Genome Database temporary ID:2733]) and are aligned with bovine IFNA [Genbank:DQ396807]. 
The mature coding sequence of the three potentially expressed IFNX genes differs as follows 164 amino acids (aa) for Glean 
24310, 163 aa for Glean 24314, and 124 aa for 24316. Conserved cysteine residues form disulfide bonds in IFNA between posi-
tions 1→99 and 29→139 and are shown in yellow. Glean 24316 has an early stop codon that eliminates the second disulfide 
bond, but both Glean 24314 and Glean 24310 encode these conserved residues. Regions strongly associated with receptor 
binding in IFNA, or interferon receptor recognition peptides (IRRP), are boxed in blue.Page 13 of 15
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BMC Genomics 2009, 10:187 http://www.biomedcentral.com/1471-2164/10/187Type I IFN might also have been gained, such as the one
exemplified by the IFNT, whose appearance coincided
with, and possibly permitted, the acquisition of the
unique, synepitheliochorial placentation that character-
izes the Ruminantia sub-order and requires powerful con-
ceptus signaling before the trophoblast has even attached
to the uterine wall [24]. The ancient Type III IFN (IFNL/
IL28-29) may have become a casualty of the expansion
and broadened the role of the Type I locus, as only an
inactive IFNL remains in the bovine genome. It is tempt-
ing to speculate that the function of IFNL has been
replaced as the component genes of the Type I IFN locus
expanded.
The authors concede that the bovine genome assembly is
a work in progress and that the predicted arrangement of
individual IFN genes may have to be modified as data are
reanalyzed. In addition, it is clear that an individual ani-
mal possesses unique genomic peculiarities, including
inversions, duplications, and presence and absence of spe-
cific genes and that the IFN locus of a single Hereford cow
may not be replicated precisely in other breeds. Neverthe-
less, with the exception of the size of the "gap" between
the two sub-loci, the organization and sequence of the
bovine Type I IFN have remained relatively constant
through the most recent assemblies. The unique features
of the locus, which include the presence of the gap itself,
the arrangements of IFNW/IFNA clusters, the dramatic
expansion of the IFNW, the presence of the IFNX, and the
separation of IFNT from the IFNW/IFNA clusters are con-
sistent observations and unlikely to undergo drastic re-
evaluation in future versions of the assembly.
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